Evidence map›Paper›PMID 30275297›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Copper inhibits peptidoglycan LD-transpeptidases suppressing β-lactam resistance due to bypass of penicillin-binding proteins.

Katharina Peters, Manuel Pazos, Zainab Edoo, Jean-Emmanuel Hugonnet, Alessandra M Martorana, Alessandra Polissi, Michael S VanNieuwenhze, Michel Arthur, Waldemar Vollmer

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 78 citations in OpenAlex.

  1. Virulence · 2026
    Article
  2. Review
  3. Peptidoglycan LD-Transpeptidases.Antibiotics (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Frontiers in microbiology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Katharina PetersCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, NE2 4AX Newcastle upon Tyne, United Kingdom.
Manuel PazosCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, NE2 4AX Newcastle upon Tyne, United Kingdom.
Zainab EdooSorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, INSERM, Centre de Recherche des Cordeliers, CRC, 75006 Paris, France.
Jean-Emmanuel HugonnetSorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, INSERM, Centre de Recherche des Cordeliers, CRC, 75006 Paris, France.ORCID 0000-0003-4150-0944
Alessandra M MartoranaDipartimento di Scienze Farmacolgiche e Biomolecolari, Universita degli Studi di Milano, 20122 Milano, Italy.
Alessandra PolissiDipartimento di Scienze Farmacolgiche e Biomolecolari, Universita degli Studi di Milano, 20122 Milano, Italy.
Michael S VanNieuwenhzeDepartment of Chemistry, Indiana University, Bloomington, IN 47405.ORCID 0000-0001-6093-5949
Michel ArthurSorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, INSERM, Centre de Recherche des Cordeliers, CRC, 75006 Paris, France.
Waldemar VollmerCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, NE2 4AX Newcastle upon Tyne, United Kingdom; w.vollmer@ncl.ac.uk.
Délégation Paris 5 · FRNewcastle University · GBUniversity of Milan · ITIndiana University Bloomington · US

Funding

Dynamics of bacterial peptidoglycan synthesisR01GM113172 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI BRUN, YVES V, VANNIEUWENHZE, MICHAEL S · 2015 to 2018
$3.5M
Medical Research Council MR/N002679/1Medical Research Council MR/N501840/1NIGMS NIH HHS R01 GM113172Wellcome TrustWellcome Trust 101824/Z/13/Z
6 · The paper itself

Abstract

The peptidoglycan (PG) layer stabilizes the bacterial cell envelope to maintain the integrity and shape of the cell. Penicillin-binding proteins (PBPs) synthesize essential 4-3 cross-links in PG and are inhibited by β-lactam antibiotics. Some clinical isolates and laboratory strains of

Indexed as

AminoacyltransferasesAnti-Bacterial Agentsbeta-Lactam Resistancebeta-LactamsCell WallCopperEnterococcus faeciumEscherichia coliMicrobial Sensitivity TestsPenicillin-Binding ProteinsPeptidoglycanSubstrate SpecificityTrace ElementsAminoacyltransferasesAnti-Bacterial Agentsbeta-LactamsCopperPenicillin-Binding ProteinsPeptidoglycanpeptidoglycan transpeptidaseTrace ElementscopperEnterococcus faeciumEscherichia coliLD-transpeptidasepeptidoglycan

Identifiers

PMID30275297
PMCPMC6196517
OpenAlexW2895658265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.